Impact of Oxidized Phospholipids on Outcomes from Cerebral Ischemia and Reperfusion Injury

Read full text
Authors: Jin Yu, Hong Zhu, Taheri Saeid, William Lafayette Mondy, Cheryl L. Kirstein, Mark S. Kindy
Cited by: 0
References: 62

Abstract

Background/Objectives: The mechanisms leading to oxidative stress and cellular dysfunction during stroke are not well understood. Methods: We tested if transient cerebral artery occlusion (MCAo) in mice results in the generation of oxidized phospholipids (OxPLs) that contribute to neuronal cell death and glial activation. Results: Both in vitro and in vivo cerebral ischemia and reperfusion injury (IRI) resulted in the elevation of specific OxPLs. Neuronal cell death was determined in the presence of OxPLs and the natural OxPL E06 antibody (antioxidized phospholipid antibody) protected the cells from the toxic effects. IRI in mice gave rise to increased immunoreactivity of OxPLs in the brain. E06 reduced inflammatory markers in the brain following IRI, including iba-1, GFAP and inflammatory cytokines. In addition, OxPLs gave rise to M1 and Mox microglial phenotypes which was reversed in the presence of E06 and elicited a more M2 phenotype. Nrf2-deficient mice showed increased infarct volumes and microglia from Nrf2−/− mice showed a reduction in Mox gene expression, and E06 protects both mice and cells from the Nrf2-deficit. Finally, AB1-2 Ab which recognizes the E06 Ab, ameliorates the impact of E06 Ab on infarct volume in the mouse model. Conclusions: Taken together, the data indicate that OxPLs play an important role in inflammation and neuronal cell loss in cerebral IRI and inactivation of OxPLs may provide novel targets for potential drug targets in the treatment of stroke.

Fields of Study & Subjects

Neuroinflammation and Neurodegeneration Mechanisms Acute Ischemic Stroke Management Neurological Disorders and Treatments

Publication details

Journal / source
Pharmaceutics
Volume
18
Issue
2
Pages
203–203
Publication date
4 February 2026
Language
EN